Mercer Global Advisors Inc. ADV Increases Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Mercer Global Advisors Inc. ADV increased its holdings in Mettler-Toledo International Inc. (NYSE:MTD – Get Rating) by 42.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 437 shares of the medical instruments supplier’s stock after acquiring an additional 131 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in Mettler-Toledo International were worth $632,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CVA Family Office LLC lifted its stake in Mettler-Toledo International by 53.3% in the third quarter. CVA Family Office LLC now owns 23 shares of the medical instruments supplier’s stock worth $25,000 after acquiring an additional 8 shares during the period. Allworth Financial LP raised its holdings in Mettler-Toledo International by 43.8% in the fourth quarter. Allworth Financial LP now owns 23 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 7 shares in the last quarter. Guardian Wealth Advisors LLC bought a new position in Mettler-Toledo International in the third quarter worth $35,000. Bell Investment Advisors Inc raised its holdings in Mettler-Toledo International by 84.6% in the fourth quarter. Bell Investment Advisors Inc now owns 24 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 11 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in Mettler-Toledo International by 250.0% in the third quarter. EverSource Wealth Advisors LLC now owns 35 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 25 shares in the last quarter. Hedge funds and other institutional investors own 91.94% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on MTD. Wells Fargo & Company decreased their price objective on Mettler-Toledo International from $1,675.00 to $1,660.00 in a report on Monday, May 8th. 51job reiterated a “maintains” rating on shares of Mettler-Toledo International in a report on Monday, May 8th. TheStreet upgraded Mettler-Toledo International from a “c+” rating to a “b-” rating in a report on Thursday, February 2nd. StockNews.com initiated coverage on Mettler-Toledo International in a report on Thursday. They set a “buy” rating for the company. Finally, Robert W. Baird reduced their price target on Mettler-Toledo International from $1,513.00 to $1,454.00 in a report on Monday, May 8th. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $1,469.50.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,386.47 on Friday. Mettler-Toledo International Inc. has a one year low of $1,065.55 and a one year high of $1,615.97. The stock has a 50-day moving average of $1,479.00 and a 200 day moving average of $1,472.89. The company has a market capitalization of $30.53 billion, a price-to-earnings ratio of 35.21, a PEG ratio of 2.36 and a beta of 1.17. The company has a debt-to-equity ratio of 76.98, a quick ratio of 0.86 and a current ratio of 1.28.

Mettler-Toledo International (NYSE:MTD – Get Rating) last released its quarterly earnings data on Thursday, May 4th. The medical instruments supplier reported $8.69 EPS for the quarter, topping the consensus estimate of $8.61 by $0.08. Mettler-Toledo International had a negative return on equity of 4,833.51% and a net margin of 22.45%. The company had revenue of $928.70 million during the quarter, compared to the consensus estimate of $921.19 million. During the same period last year, the company earned $7.87 EPS. Mettler-Toledo International’s revenue for the quarter was up 3.4% on a year-over-year basis. On average, sell-side analysts forecast that Mettler-Toledo International Inc. will post 43.94 EPS for the current year.

Insider Buying and Selling

In related news, Director Olivier A. Filliol sold 10,000 shares of Mettler-Toledo International stock in a transaction dated Tuesday, February 28th. The stock was sold at an average price of $1,433.61, for a total value of $14,336,100.00. Following the completion of the sale, the director now directly owns 71 shares in the company, valued at approximately $101,786.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Mettler-Toledo International news, Director Olivier A. Filliol sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, February 28th. The stock was sold at an average price of $1,433.61, for a total value of $14,336,100.00. Following the transaction, the director now directly owns 71 shares of the company’s stock, valued at $101,786.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Shawn Vadala sold 880 shares of the firm’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $1,360.61, for a total value of $1,197,336.80. Following the completion of the transaction, the chief financial officer now directly owns 4,900 shares in the company, valued at $6,666,989. The disclosure for this sale can be found here. In the last ninety days, insiders sold 16,261 shares of company stock worth $23,364,037. 2.40% of the stock is owned by corporate insiders.

About Mettler-Toledo International

(Get Rating)

Mettler-Toledo International, Inc engages in the provision of precision instruments and services. The firm manufactures weighing instruments for use in laboratory, industrial, packaging, logistics, and food retailing applications. It also manufactures several related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development, metal detection and other end-of-line inspection systems used in production and packaging and provides solutions for use in certain process analytics applications.